• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床阶段抗体与血红素的相互作用可预测其物理化学性质和结合特性。

Interaction of clinical-stage antibodies with heme predicts their physiochemical and binding qualities.

机构信息

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, F-75006, Paris, France.

出版信息

Commun Biol. 2021 Mar 23;4(1):391. doi: 10.1038/s42003-021-01931-7.

DOI:10.1038/s42003-021-01931-7
PMID:33758329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7988133/
Abstract

Immunoglobulin repertoires contain a fraction of antibodies that recognize low molecular weight compounds, including some enzymes' cofactors, such as heme. Here, by using a set of 113 samples with variable region sequences matching clinical-stage antibodies, we demonstrated that a considerable number of these antibodies interact with heme. Antibodies that interact with heme possess specific sequence traits of their antigen-binding regions. Moreover they manifest particular physicochemical and functional qualities i.e. increased hydrophobicity, higher propensity of self-binding, higher intrinsic polyreactivity and reduced expression yields. Thus, interaction with heme is a strong predictor of different molecular and functional qualities of antibodies. Notably, these qualities are of high importance for therapeutic antibodies, as their presence was associated with failure of drug candidates to reach clinic. Our study reveled an important facet of information about relationship sequence-function in antibodies. It also offers a convenient tool for detection of liabilities of therapeutic antibodies.

摘要

免疫球蛋白库中包含一部分能够识别小分子化合物的抗体,包括一些酶的辅因子,如血红素。在这里,我们使用了一组 113 个具有匹配临床阶段抗体可变区序列的样本,证明了相当数量的这些抗体与血红素相互作用。与血红素相互作用的抗体具有其抗原结合区域的特定序列特征。此外,它们表现出特殊的物理化学和功能特性,即增加疏水性、更高的自结合倾向、更高的固有多反应性和降低表达产量。因此,与血红素的相互作用是抗体不同分子和功能特性的强有力预测因子。值得注意的是,这些特性对于治疗性抗体非常重要,因为它们的存在与候选药物未能进入临床阶段有关。我们的研究揭示了抗体中序列-功能关系信息的一个重要方面。它还为检测治疗性抗体的缺陷提供了一个方便的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/b1bfb3d6ac40/42003_2021_1931_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/e714b6867757/42003_2021_1931_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/c54896c46d8f/42003_2021_1931_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/8a6339bc6f4c/42003_2021_1931_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/64b4f03a5116/42003_2021_1931_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/25ff6aea31e3/42003_2021_1931_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/a2a13af3ba04/42003_2021_1931_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/b1bfb3d6ac40/42003_2021_1931_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/e714b6867757/42003_2021_1931_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/c54896c46d8f/42003_2021_1931_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/8a6339bc6f4c/42003_2021_1931_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/64b4f03a5116/42003_2021_1931_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/25ff6aea31e3/42003_2021_1931_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/a2a13af3ba04/42003_2021_1931_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f9e/7988133/b1bfb3d6ac40/42003_2021_1931_Fig7_HTML.jpg

相似文献

1
Interaction of clinical-stage antibodies with heme predicts their physiochemical and binding qualities.临床阶段抗体与血红素的相互作用可预测其物理化学性质和结合特性。
Commun Biol. 2021 Mar 23;4(1):391. doi: 10.1038/s42003-021-01931-7.
2
Mechanism and functional implications of the heme-induced binding promiscuity of IgE.血红素诱导的IgE结合多特异性的机制及其功能意义
Biochemistry. 2015 Mar 24;54(11):2061-72. doi: 10.1021/bi501507m. Epub 2015 Mar 11.
3
Relationship between natural and heme-mediated antibody polyreactivity.天然抗体与血红素介导的抗体多反应性之间的关系。
Biochem Biophys Res Commun. 2016 Mar 25;472(1):281-6. doi: 10.1016/j.bbrc.2016.02.112. Epub 2016 Feb 27.
4
Sequence features of variable region determining physicochemical properties and polyreactivity of therapeutic antibodies.可变区序列特征决定治疗性抗体的理化性质和多反应性。
Mol Immunol. 2019 Aug;112:338-346. doi: 10.1016/j.molimm.2019.06.012. Epub 2019 Jun 26.
5
Interaction with 2,4-dinitrophenol correlates with polyreactivity, self-binding, and stability of clinical-stage therapeutic antibodies.与 2,4-二硝基苯酚的相互作用与临床阶段治疗性抗体的多反应性、自结合和稳定性相关。
Mol Immunol. 2021 Dec;140:233-239. doi: 10.1016/j.molimm.2021.10.019. Epub 2021 Nov 10.
6
Prevalence and gene characteristics of antibodies with cofactor-induced HIV-1 specificity.具有辅因子诱导的HIV-1特异性抗体的流行率和基因特征
J Biol Chem. 2015 Feb 20;290(8):5203-5213. doi: 10.1074/jbc.M114.618124. Epub 2015 Jan 6.
7
Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.针对B细胞受体相关蛋白31上相同表位的两种单克隆抗体的分子特征分析
PLoS One. 2016 Dec 1;11(12):e0167527. doi: 10.1371/journal.pone.0167527. eCollection 2016.
8
Methods for Posttranslational Induction of Polyreactivity of Antibodies.抗体多反应性的翻译后诱导方法。
Methods Mol Biol. 2017;1643:135-145. doi: 10.1007/978-1-4939-7180-0_10.
9
A central core structure in an antibody variable domain determines antigen specificity.
Protein Eng. 2001 Jan;14(1):67-74. doi: 10.1093/protein/14.1.67.
10
Cryptic polyreactivity of IgG expressed by splenic marginal zone B-cell lymphoma.脾脏边缘区 B 细胞淋巴瘤表达的免疫球蛋白 IgG 的隐匿性多反应性。
Mol Immunol. 2014 Jul;60(1):54-61. doi: 10.1016/j.molimm.2014.03.009. Epub 2014 Apr 24.

引用本文的文献

1
DOTAD: A Database of Therapeutic Antibody Developability.DOTAD:治疗性抗体可开发性数据库。
Interdiscip Sci. 2024 Sep;16(3):623-634. doi: 10.1007/s12539-024-00613-2. Epub 2024 Mar 26.
2
Polyreactivity of antibodies from different B-cell subpopulations is determined by distinct sequence patterns of variable region.不同 B 细胞亚群的抗体的多反应性由可变区的不同序列模式决定。
Front Immunol. 2023 Nov 23;14:1266668. doi: 10.3389/fimmu.2023.1266668. eCollection 2023.
3
Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches.

本文引用的文献

1
Method for identification of heme-binding proteins and quantification of their interactions.鉴定血红素结合蛋白及其相互作用定量的方法。
Anal Biochem. 2020 Oct 15;607:113865. doi: 10.1016/j.ab.2020.113865. Epub 2020 Jul 29.
2
Antibodies to watch in 2020.2020 年值得关注的抗体药物
MAbs. 2020 Jan-Dec;12(1):1703531. doi: 10.1080/19420862.2019.1703531.
3
Heparin chromatography as an predictor for antibody clearance rate through pinocytosis.肝素亲和层析预测抗体通过胞饮作用的清除率。
利用高通量体外和计算方法鉴定抗体临床进展的可开发性风险。
MAbs. 2023 Jan-Dec;15(1):2200540. doi: 10.1080/19420862.2023.2200540.
4
Hyperoxidized Species of Heme Have a Potent Capacity to Induce Autoreactivity of Human IgG Antibodies.过氧化物物种的血红素有强烈的诱导人 IgG 抗体自身反应性的能力。
Int J Mol Sci. 2023 Feb 8;24(4):3416. doi: 10.3390/ijms24043416.
5
Oxidized hemoglobin triggers polyreactivity and autoreactivity of human IgG via transfer of heme.氧化血红蛋白通过血红素转移触发人 IgG 的多反应性和自身反应性。
Commun Biol. 2023 Feb 11;6(1):168. doi: 10.1038/s42003-023-04535-5.
6
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties.拓展具有类药性理化性质的抗体的发现和筛选的常规工具包的方法。
MAbs. 2023 Jan-Dec;15(1):2164459. doi: 10.1080/19420862.2022.2164459.
7
Functional Changes of Therapeutic Antibodies upon Exposure to Pro-Oxidative Agents.治疗性抗体暴露于促氧化剂后的功能变化
Antibodies (Basel). 2022 Feb 2;11(1):11. doi: 10.3390/antib11010011.
MAbs. 2020 Jan-Dec;12(1):1683432. doi: 10.1080/19420862.2019.1683432.
4
Binding of Immunoglobulin G to Protoporphyrin IX and Its Derivatives: Evidence the Fab Domain Recognizes the Protoporphyrin Ring.免疫球蛋白G与原卟啉IX及其衍生物的结合:Fab结构域识别原卟啉环的证据
Antibodies (Basel). 2019 Jan 4;8(1):6. doi: 10.3390/antib8010006.
5
Sequence features of variable region determining physicochemical properties and polyreactivity of therapeutic antibodies.可变区序列特征决定治疗性抗体的理化性质和多反应性。
Mol Immunol. 2019 Aug;112:338-346. doi: 10.1016/j.molimm.2019.06.012. Epub 2019 Jun 26.
6
Net charge of antibody complementarity-determining regions is a key predictor of specificity.抗体互补决定区的净电荷是特异性的关键预测指标。
Protein Eng Des Sel. 2018 Nov 1;31(11):409-418. doi: 10.1093/protein/gzz002.
7
Five computational developability guidelines for therapeutic antibody profiling.五项治疗性抗体分析的计算可开发性指南。
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4025-4030. doi: 10.1073/pnas.1810576116. Epub 2019 Feb 14.
8
Breaking the law: unconventional strategies for antibody diversification.违法:抗体多样化的非常规策略。
Nat Rev Immunol. 2019 Jun;19(6):355-368. doi: 10.1038/s41577-019-0126-7.
9
The molecular basis of transient heme-protein interactions: analysis, concept and implementation.瞬时血红素蛋白相互作用的分子基础:分析、概念与实现。
Biosci Rep. 2019 Jan 30;39(1). doi: 10.1042/BSR20181940. Print 2019 Jan 31.
10
Structure, heterogeneity and developability assessment of therapeutic antibodies.治疗性抗体的结构、异质性和可开发性评估。
MAbs. 2019 Feb/Mar;11(2):239-264. doi: 10.1080/19420862.2018.1553476. Epub 2018 Dec 17.